These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17540562)

  • 1. Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
    Belema M; Bunker A; Nguyen VN; Beaulieu F; Ouellet C; Qiu Y; Zhang Y; Martel A; Burke JR; McIntyre KW; Pattoli MA; Daloisio C; Gillooly KM; Clarke WJ; Brassil PJ; Zusi FC; Vyas DM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4284-9. PubMed ID: 17540562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-alpha and IKK-beta kinases.
    Christopher JA; Avitabile BG; Bamborough P; Champigny AC; Cutler GJ; Dyos SL; Grace KG; Kerns JK; Kitson JD; Mellor GW; Morey JV; Morse MA; O'Malley CF; Patel CB; Probst N; Rumsey W; Smith CA; Wilson MJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3972-7. PubMed ID: 17502144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolopyrazinedione-based inhibitors of human hormone-sensitive lipase.
    Slee DH; Bhat AS; Nguyen TN; Kish M; Lundeen K; Newman MJ; McConnell SJ
    J Med Chem; 2003 Mar; 46(7):1120-2. PubMed ID: 12646020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines.
    Suzuki Y; Cluzeau J; Hara T; Hirasawa A; Tsujimoto G; Oishi S; Ohno H; Fujii N
    Arch Pharm (Weinheim); 2008 Sep; 341(9):554-61. PubMed ID: 18763715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.
    Jin H; Cianchetta G; Devasagayaraj A; Gu K; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; David Kimball S; Main AJ; Ding ZM; Sun W; Yang Q; Yu XQ; Powell DR; Wilson A; Liu Q; Shi ZC
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5229-32. PubMed ID: 19631532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors.
    Ioannidis S; Lamb ML; Davies AM; Almeida L; Su M; Bebernitz G; Ye M; Bell K; Alimzhanov M; Zinda M
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6524-8. PubMed ID: 19857966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMS.
    Burns CJ; Harte MF; Bu X; Fantino E; Giarrusso M; Joffe M; Kurek M; Legge FS; Razzino P; Su S; Treutlein H; Wan SS; Zeng J; Wilks AF
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1206-9. PubMed ID: 19128971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).
    Christopher JA; Bamborough P; Alder C; Campbell A; Cutler GJ; Down K; Hamadi AM; Jolly AM; Kerns JK; Lucas FS; Mellor GW; Miller DD; Morse MA; Pancholi KD; Rumsey W; Solanke YE; Williamson R
    J Med Chem; 2009 May; 52(9):3098-102. PubMed ID: 19348415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A straightforward microwave method for rapid synthesis of N-1, C-6 functionalized 3,5-dichloro-2(1H)-pyrazinones.
    Gising J; Ortqvist P; Sandström A; Larhed M
    Org Biomol Chem; 2009 Jul; 7(13):2809-15. PubMed ID: 19532999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
    Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel dihydrothieno[2,3-e]indazole derivatives as IκB kinase inhibitors.
    Takahashi H; Shinoyama M; Komine T; Nagao M; Suzuki M; Tsuchida H; Katsuyama K
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1758-62. PubMed ID: 21316233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.
    Mukaiyama H; Nishimura T; Kobayashi S; Ozawa T; Kamada N; Komatsu Y; Kikuchi S; Oonota H; Kusama H
    Bioorg Med Chem; 2007 Jan; 15(2):868-85. PubMed ID: 17095233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.
    Han Y; Giroux A; Colucci J; Bayly CI; Mckay DJ; Roy S; Xanthoudakis S; Vaillancourt J; Rasper DM; Tam J; Tawa P; Nicholson DW; Zamboni RJ
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1173-80. PubMed ID: 15686936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase.
    Milkiewicz KL; Weinberg LR; Albom MS; Angeles TS; Cheng M; Ghose AK; Roemmele RC; Theroff JP; Underiner TL; Zificsak CA; Dorsey BD
    Bioorg Med Chem; 2010 Jun; 18(12):4351-62. PubMed ID: 20483621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
    Kempson J; Guo J; Das J; Moquin RV; Spergel SH; Watterson SH; Langevine CM; Dyckman AJ; Pattoli M; Burke JR; Yang X; Gillooly KM; McIntyre KW; Chen L; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
    Bioorg Med Chem Lett; 2009 May; 19(10):2646-9. PubMed ID: 19376699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
    Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
    J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
    Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors.
    Patinote C; Bou Karroum N; Moarbess G; Deleuze-Masquefa C; Hadj-Kaddour K; Cuq P; Diab-Assaf M; Kassab I; Bonnet PA
    Eur J Med Chem; 2017 Sep; 138():909-919. PubMed ID: 28750313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.